logo

For the Inventor, By the Inventor

Aachen, Germany

Robert Frank

This inventor holds 30 USPTO granted patents and 7 published patent applications and 13 EPO patents, primarily in Pain Management Compounds. Top assignee: Gruenenthal Gmbh. Active years: 2009-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert Frank. Retrieved from https://idiyas.com/inventor/robert-frank

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 30 

% Patents Active = 6.7

 

Average Co-Inventor Count = 5.9

ph-index = 7

Forward Citations = 104(Granted Patents)


Company Filing History:

goldMedal30 out of 361 
 
Gruenenthal Gmbh
 patents

Years Active: 2009-2015

Loading Chart...
Loading Chart...
Areas of Expertise:
Vanilloid Receptor Ligands
Pharmaceutical Compositions
Analgesics
Pain Relief
Substituted Phenylureas
Bicyclic Aromatic Carboxamides
Methanesulfonamide Derivatives
Spiro Compounds
Tetrahydropyrrolopyrazine
Nicotinamide Compounds
Drug Production
Cyclohexanone Derivatives
30 patents (USPTO):Explore Patents
1. 9120756 - Substituted phenylureas and phenylamides as vanilloid receptor ligands (2015-09-01),
2. 9029378 - Substituted bicyclic aromatic carboxamide and urea compounds as vanilloid receptor ligands (2015-05-12),
3. 8946204 - Substituted phenylureas and phenylamides as vanilloid receptor ligands (2015-02-03),
4. 8937092 - Aryl or N-heteroaryl substituted methanesulfonamide derivatives as vanilloid receptor ligands (2015-01-20),
5. 8791268 - Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof for treating pain and other conditions (2014-07-29),
6. 8785474 - Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof to treat pain and other conditions (2014-07-22),
7. 8772307 - Substituted spiro compounds and their use for producing pain-relief medicaments (2014-07-08),
8. 8765733 - Amine substituted methanesulfonamide derivatives as vanilloid receptor ligands (2014-07-01),
9. 8735426 - Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them and use thereof for treating pain and other conditions (2014-05-27),
10. 8710233 - Vanilloid receptor ligands and use thereof for the production of pharmaceutical preparations (2014-04-29),
11. 8642775 - Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof for treating pain and other conditions (2014-02-04),
12. 8642623 - Vanilloid receptor ligand compounds, pharmaceutical compositions containing them, a method of producing them and the use thereof to treat pain and various other conditions (2014-02-04),
13. 8592471 - Substituted phenylureas and phenylamides as vanilloid receptor ligands (2013-11-26),
14. 8334315 - Substituted aromatic carboxamide and urea derivatives as vanilloid receptor ligands (2012-12-18),
15. 8252816 - Vanilloid receptor ligand compounds, pharmaceutical compositions containing them, a method of producing them and the use thereof to treat pain and various other conditions (2012-08-28),

As an AI specialized in innovations, inventions, inventors, patent attorneys, assignees, and patents, I can provide you with an article about inventor Robert Frank based on the data you have shared.

Title: The Innovator: Robert Frank from Aachen, DE

Introduction:

Robert Frank, a prolific inventor hailing from Aachen, Germany, has made significant contributions to the field of pharmaceuticals with over 30 patents to his name.

Latest Patents:

1. "Substituted phenylureas and phenylamides as vanilloid receptor ligands": This invention pertains to substituted phenylureas and phenylamides, their preparation processes, pharmaceutical compositions incorporating these compounds, and their use in pharmaceutical formulations.

2. "Substituted bicyclic aromatic carboxamide and urea compounds as vanilloid receptor ligands": Robert Frank's innovation involves substituted bicyclic aromatic carboxamide and urea compounds as vanilloid receptor ligands, with a focus on their application in pain treatment and managing diseases mediated via the vanilloid receptor 1 (VR1/TRPV1).

Career Highlights:

Robert Frank is a valuable member of Gruenenthal GmbH, a pharmaceutical company known for its groundbreaking research and development initiatives.

Collaborations:

Among his esteemed colleagues, Robert Frank has worked closely with Gregor Bahrenberg and Thomas Christoph, further enhancing his innovative endeavors.

Conclusion:

In conclusion, Robert Frank's remarkable portfolio of patents and his dedication to advancing pharmaceutical science exemplify his status as a trailblazing inventor in the industry. His collaborations and achievements at Gruenenthal GmbH solidify his reputation as a visionary in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…